{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T13:04:48Z","timestamp":1745240688683},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T00:00:00Z","timestamp":1403308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11102-014-0582-9","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T15:40:22Z","timestamp":1403278822000},"page":"359-365","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Up-to 5-year efficacy of pasireotide in a patient with Cushing\u2019s disease and pre-existing diabetes: literature review and clinical practice considerations"],"prefix":"10.1007","volume":"18","author":[{"given":"Laura","family":"Trementino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Cardinaletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Concettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Marcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,21]]},"reference":[{"key":"582_CR1","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M (2008) Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 93:2454\u20132462","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1227\/01.NEU.0000313117.35824.9F","volume":"63","author":"CG Patil","year":"2008","unstructured":"Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER Jr (2008) Outcomes after repeat transsphenoidal surgery for recurrent Cushing\u2019s disease. Neurosurgery 63:266\u2013270","journal-title":"Neurosurgery"},{"key":"582_CR3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/ncpendmet0947","volume":"4","author":"MK Aghi","year":"2008","unstructured":"Aghi MK (2008) Management of recurrent and refractory Cushing disease. Nat Clin Pract Endocrinol Metab 4:560\u2013568","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"582_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2265.2007.03028.x","volume":"68","author":"KR Mullan","year":"2008","unstructured":"Mullan KR, Atkinson B (2008) Endocrine clinical update: Where are we in the therapeutic management of pituitary-dependent hypercortisolism? Clin Endocrinol 68:327\u2013337","journal-title":"Clin Endocrinol"},{"key":"582_CR5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/13543784.2010.495943","volume":"19","author":"G Arnaldi","year":"2010","unstructured":"Arnaldi G, Boscaro M (2010) Pasireotide for the treatment of Cushing\u2019s disease. Expert Opin Investig Drugs 19:889\u2013898","journal-title":"Expert Opin Investig Drugs"},{"key":"582_CR6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","volume":"94","author":"M Boscaro","year":"2009","unstructured":"Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J (2009) Treatment of pituitary dependent Cushing\u2019s disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab 94:115\u2013122","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","volume":"366","author":"A Colao","year":"2012","unstructured":"Colao A, Petersenn S, Newell-Price J, Findling JW, Gu F, Maldonado M, Schoenherr U, Mills D, Salgado LR, Biller BM (2012) Pasireotide B2305 Study Group: a 12-month phase 3 study of pasireotide in Cushing\u2019s disease. N Engl J Med 366:914\u2013924","journal-title":"N Engl J Med"},{"key":"582_CR8","doi-asserted-by":"crossref","unstructured":"Pivonello, R., Petersenn, S., Newell-Price, J., Findling, J.W., Gu, F., Maldonado, M., Trovato, A., Hughes, G., Salgado, L.R., Lacroix, A., Schopohl, J., Biller, B.M.; Pasireotide B2305 Study Group. Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing\u2019s disease: results from a Phase III study. Clin. Endocrinol. (Oxf) Feb 17, (2014) [Epub ahead of print]","DOI":"10.1111\/cen.12431"},{"issue":"2","key":"582_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12020-013-0013-0","volume":"44","author":"H Raff","year":"2013","unstructured":"Raff H (2013) Update on late-night salivary cortisol for the diagnosis of Cushing\u2019s syndrome: methodological considerations. Endocrine 44(2):346\u2013349","journal-title":"Endocrine"},{"key":"582_CR10","doi-asserted-by":"crossref","unstructured":"Colao, A., Boscaro, M., Ferone, D., Casanueva, F.F. Managing Cushing\u2019s disease: the state of the art. Endocrine. Jan 11, (2014) [Epub ahead of print]","DOI":"10.1007\/s12020-013-0129-2"},{"key":"582_CR11","doi-asserted-by":"crossref","unstructured":"Trementino, L., Cardinaletti, M., Concettoni, C., Marcelli, G., Polenta, B., Spinello, M., Boscaro, M., Arnaldi, G. Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing\u2019s disease. Pituitary. Jan 31, (2014) [Epub ahead of print]","DOI":"10.1007\/s11102-014-0557-x"},{"key":"582_CR12","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/jc.2009-2272","volume":"95","author":"S Petersenn","year":"2010","unstructured":"Petersenn S, Schopohl J, Barkan A, Mohideen P, Colao A, Abs R, Buchelt A, Ho YY, Hu K, Farrall AJ, Melmed S, Biller BM (2010) Pasireotide Acromegaly Study Group: pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, Phase II trial. J Clin Endocrinol Metab 95:2781\u20132789","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR13","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jc.2003-030871","volume":"88","author":"G Arnaldi","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing\u2019s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593\u20135602","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/BF03345431","volume":"35","author":"G Arnaldi","year":"2012","unstructured":"Arnaldi G, Mancini T, Tirabassi G, Trementino L, Boscaro M (2012) Advances in the epidemiology, pathogenesis, and management of Cushing\u2019s syndrome complications. J Endocrinol Invest 35:434\u2013448","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"582_CR15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tem.2011.09.001","volume":"22","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Gazzaruso C, Giustina A (2011) Diabetes in Cushing syndrome: basic and clinical aspects. Trends Endocrinol Metab 22(12):499\u2013506","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"582_CR16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/jc.2008-2332","volume":"94","author":"G Mazziotti","year":"2009","unstructured":"Mazziotti G, Floriani I, Bonadonna S, Torri V, Chanson P, Giustina A (2009) Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. J Clin Endocrinol Metab 94(5):1500\u20131508","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR17","unstructured":"Shenouda, M., Maldonado, M., Wang, Y., Bouillaud, E., Hudson, M., Nesheiwat, D., Hu, K.: An open-label, dose-escalation study of once- and twice-daily pasireotide in healthy volunteers: Safety, tolerability and effects on glucose, insulin and glucagon levels. Am. J. Ther. Jun 16, (2012) [Epub ahead of print]"},{"issue":"8","key":"582_CR18","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2013-1771","volume":"98","author":"RR Henry","year":"2013","unstructured":"Henry RR, Ciaraldi TP, Armstrong D, Burke P, Ligueros-Saylan M, Mudaliar S (2013) Hyperglycemia associated with pasireotide:results from a mechanistic study in healthy volunteers. J Clin Endocrinol Metab 98(8):3446\u20133453","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR19","doi-asserted-by":"crossref","unstructured":"Colao, A., De Block, C., Gaztambide, M.S., Kumar, S., Seufert, J., Casanueva, F.F.: Managing hyperglycemia in patients with Cushing\u2019s disease treated with pasireotide: medical expert recommendations. Pituitary. Apr 7, (2013) [Epub ahead of print]","DOI":"10.1007\/s11102-013-0483-3"},{"key":"582_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabet.2012.10.005","volume":"39","author":"Y Reznik","year":"2013","unstructured":"Reznik Y, Bertherat J, Borson-Chazot F, Brue T, Chanson P, Cortet-Rudelli C, Delemer B, Tabarin A, Bisot-Locard S, Verg\u00e8s B (2013) Management of hyperglycaemia in Cushing\u2019s disease: experts\u2019 proposals on the use of pasireotide. Diabetes Metab 39:34\u201341","journal-title":"Diabetes Metab"},{"issue":"6","key":"582_CR21","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35(6):1364\u20131379","journal-title":"Diabetes Care"},{"key":"582_CR22","doi-asserted-by":"crossref","unstructured":"American Diabetes Association.: Standards of medical care in diabetes\u20132012. Diabetes. Care. 35 Suppl 1, S11\u201363 (2012)","DOI":"10.2337\/dc12-s011"},{"key":"582_CR23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","volume":"75","author":"R Giordano","year":"2011","unstructured":"Giordano R, Picu A, Marinazzo E, D\u2019Angelo V, Berardelli R, Karamouzis I, Forno D, Zinn\u00e0 D, Maccario M, Ghigo E, Arvat E (2011) Metabolic and cardiovascular outcomes in patients with Cushing\u2019s syndrome of different aetiologies during active disease and 1\u00a0year after remission. Clin Endocrinol 75:354\u2013360","journal-title":"Clin Endocrinol"},{"key":"582_CR24","first-page":"2664","volume":"84","author":"A Colao","year":"1999","unstructured":"Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G (1999) Persistence of increased cardiovascular risk in patients with Cushing\u2019s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664\u20132672","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","volume":"95","author":"SM Webb","year":"2010","unstructured":"Webb SM, Mo D, Lamberts SW, Melmed S, Cavagnini F, Pecori Giraldi F, Strasburger CJ, Zimmermann AG, Woodmansee WW, International HypoCCS Advisory Board (2010) Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous Cushing\u2019s disease or non-functioning pituitary adenoma. J Clin Endocrinol Metab 95:630\u2013638","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR26","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1210\/jc.2008-1297","volume":"93","author":"B Kola","year":"2008","unstructured":"Kola B, Christ-Crain M, Lolli F, Arnaldi G, Giacchetti G, Boscaro M, Grossman AB, Korbonits M (2008) Changes in adenosine 5\u2032-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing\u2019s syndrome. J Clin Endocrinol Metab 93:4969\u20134973","journal-title":"J Clin Endocrinol Metab"},{"key":"582_CR27","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","volume":"88","author":"R Cozzi","year":"2003","unstructured":"Cozzi R, Attanasio R, Montini M, Pagani G, Lasio G, Lodrini S, Barausse M, Albizzi M, Dallabonzana D, Pedroncelli AM (2003) Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results? J Clin Endocrinol Metab 88:3090\u20133098","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"582_CR28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF03345407","volume":"34","author":"C Fiorentino","year":"2011","unstructured":"Fiorentino C, Motta C, Wolosinska DT, Monti S, Mori F, Toscano V (2011) SOM230 in Cushing\u2019s disease complicated by poorly controlled diabetes mellitus. J Endocrinol Invest 34(9):731\u2013732","journal-title":"J Endocrinol Invest"},{"key":"582_CR29","doi-asserted-by":"crossref","unstructured":"Lib\u00e9, R., Groussin, L., Bertherat, J.: Pasireotide in Cushing\u2019s disease. N. Engl. J. Med. 366(22), 2134; author reply 2134\u20132135 (2012)","DOI":"10.1056\/NEJMc1204078"},{"issue":"4","key":"582_CR30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11102-012-0427-3","volume":"15","author":"I Shimon","year":"2012","unstructured":"Shimon I, Rot L, Inbar E (2012) Pituitary-directed medical therapy with pasireotide for a orticotroph macroadenoma: pituitary volume reduction and literature review. Pituitary 15(4):608\u2013613","journal-title":"Pituitary"},{"key":"582_CR31","doi-asserted-by":"crossref","unstructured":"Boscaro, M., Bertherat, J., Findling, J., Fleseriu, M., Atkinson, A.B., Petersenn, S., Schopohl, J., Snyder, P., Hughes, G., Trovato, A., Hu, K., Maldonado, M., Biller, B.M.: Extended treatment of Cushing\u2019s disease with pasireotide: results from a 2-year, Phase II study. Pituitary. Aug 14, (2013) [Epub ahead of print]","DOI":"10.1007\/s11102-013-0503-3"},{"key":"582_CR32","first-page":"735489","volume":"2013","author":"C Yedinak","year":"2013","unstructured":"Yedinak C, Brzana J, Fleseriu M (2013) Monitoring patient improvement parameters following pasireotide treatment in Cushing\u2019s Disease. Case Rep Endocrinol 2013:735489","journal-title":"Case Rep Endocrinol"},{"issue":"4","key":"582_CR33","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.4158\/EP12296.CR","volume":"19","author":"L Lu","year":"2013","unstructured":"Lu L, Duan L, Jin Z, Lu Z, Gu F (2013) Effective long-term treatment of Cushing\u2019s disease with pasireotide: a case report. Endocr Pract 19(4):e92\u2013e96","journal-title":"Endocr Pract"},{"key":"582_CR34","doi-asserted-by":"crossref","unstructured":"Mackenzie Feder, J., Bourdeau, I., Vallette, S., Beauregard, H., Ste-Marie, L.G., Lacroix, A.: Pasireotide monotherapy in Cushing\u2019s disease: a single-centre experience with 5-year extension of phase III Trial. Pituitary. Nov 28, 2013 [Epub ahead of print]","DOI":"10.1007\/s11102-013-0539-4"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0582-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-014-0582-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-014-0582-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:30:43Z","timestamp":1649464243000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-014-0582-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,21]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1007\/s11102-014-0582-9","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,21]]}}}